PFE

#90
Pfizer Inc.
27.17 USD
-1.16%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
27.08
27.27
Jahresspanne
21.87
28.75
Tagesänderung
-1.16%
Monatliche Änderung
+1.76%
6 month change
+10.99%
Jahresänderung
+22.55%
Vorheriger Schlusskurs
27.49
Eröffnung
27.25
Bid
Ask
Tief
27.08
High
27.27
Volumen
927
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 154.5 B
  • Employee 75 K
  • Founded N/A
  • CEO Albert Bourla
  • Website www.pfizer.com
  • Headquarter Delaware, United States
  • FIGI BBG000BR2B91
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
18.31
Preis-Umsatz-Verhältnis
2.27
Dividende je Aktie
1.72
Dividendenrendite in %
6.91

Pfizer Inc

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000.

Nachrichten